Opportunity
Imatinib Tablets
Response due
October 30, 2026
- Agency
- Nac Pharmaceuticals (36E797)
- Estimated value
- Not stated
N/A
Key dates
- Posted
- October 16, 2026
- Response due
- October 30, 2026
Who is this buyer
Organization
Buying history
- Records30 total
- Opportunities / awards3 / 7
- Value range$1,932,252 – $436,529,696
- ActiveJune 10, 2026 – October 16, 2026
What they buy
- Clinical (30)
Set-asides used
- No Set aside used (1)
Also open from this buyer
- Sodium Bicarbonate Injection Vial Restricted to Made in AmericaDue October 21, 2026 · Clinical
- Tacrolimus CapsulesClinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 325412
- PSC
- 6505